Introduction to China’s veterinary drug registration system
The Ministries of Agriculture and Rural Affairs issue production licenses to all veterinary drug companies in the country. The drug-producing companies in China or importing such products into this country from other countries need to be registered. This should ensure registration; a measure that would guarantee not only the safety and efficacy of veterinary drugs used in the country but also of the health and welfare of the animals. Veterinary drug in China comes from a very active sector in recent years, as it has approved 65 new drugs in 2021.
It further increased the proportion of domestic drugs approved from 12% in 2017 to 43% in 2021, which means growing importance for domestic production became visible. The key documents required to be submitted by an applicant, along with samples of the veterinary drug, comprise the application form and a detailed technical report. The application will be subjected to classified registration administration, and the evaluation fee will have to be paid, depending on the type of drug. This will depend on the type of product, taking anywhere between 1.5 to 4 years for registration to be carried out.
Moreover, they are an integral part of the USA veterinary drugs regulation system through monitoring and reporting of adverse events that should draw the attention of its regulatory body. The importance of veterinary drug registration in China looms high, with its essence falling into place as a critical safeguard of animal health, welfare, safety, and efficacy of the usage of its veterinary drugs within the country. Such newly established guidelines are anticipated to in the future aid in standardizing and improving the quality of services rendered, quality care provided, and responsible pet ownership in veterinary institutions in China.
The further development of the veterinary drug industry in China is bound to attract enhanced attention from the regulatory agencies to the developing and growing scale of production and development in this sector to ensure safety and welfare protection to the effective use by the public.
Recent trends in China’s veterinary drug registration
In recent years, there has been an increased focus on drug safety and efficacy in China’s veterinary drug registration. Though more strictly oriented with an orientation to the scope of registration for different classes of veterinary drugs, safety, and efficacy, veterinary drugs in China should have Chinese Ministry of Agriculture and Rural Affairs pre-production, pre-import, and pre-sale registration. This momentum reflects increasing numbers of domestically approved drugs: of the 65 new drugs approved in 2021, 28 were from domestic sources. The Chinese veterinary drug registration system is based on the standard of drug safety and efficiency. It also protects the life and welfare of the animal owner.
Another trend in China’s veterinary drug registration is the streamlining of registration procedures. This move by the Chinese government clearly articulates the time frames for reviewing and approving the respective type of drug registration applications with an aim to make registration of drugs to clinical trials more efficient. All of this has streamlined and made much more efficient the process, and will enable easier entry for companies trying to bring veterinary drugs to market. China contributes to the development and promotion of veterinary drug innovation, primarily through simplification of vet registration procedures, which may result in new drugs and drug therapies for diseases of animals.
On the other hand, China has simplified the registration procedures for anyone interested in the development of veterinary drugs. Certainly, the country with the regulatory reforms since 2015 has been witnessing a new life of the innovative research and development of drugs through the development of over 100 drug products already approved. The innovation push ensured that the proportion of domestically approved drugs that were accepted in China soared from 12% in 2017 to 43% in 2021. Also expected to be rolled out are new policies prescribing the way veterinary institutions are operated in China to standardize and boost the quality of care the pets and owners receive. The veterinary drug registration system in China supports new products and further improvement in the quality of care, ensuring health and safety protection to the animal and its owner, therefore promoting the development of the veterinary industry.
Implications of these trends for veterinary drug companies operating in China
This trend may facilitate the possibility for companies with innovative products to enter the process of veterinary drug registration in China. Therefore, the new veterinary drug development and approval for animal health and welfare have been among the priority fields of the Chinese government. Accordingly, the licensing of the firms to sell their newly innovated drugs that meet the new regulating criteria has become subject to hot competition. Companies who can produce quality, efficient, and safe goods have a chance of Chinese market winning and thus getting the opportunity to expand their wing internationally.
The leading company with the innovative product will sure have great opportunity space to serve the product in this market, where demands for medical service of the animals are increasing in China. On the other hand, the companies that are not meeting the related standards are also challenged by the new related regulatory requirement. Recently, stricter regulations on the safe and efficient use of the veterinary drug have been promulgated by the Chinese Ministry of Agriculture and Rural Affairs. Those found not meeting the requirements of both will, therefore, be lost and hence not operating in the market. This might have a substantial financial impact on such companies, as the China veterinary drug market is one of the most significant worldwide and grows much faster than in other countries. Firms such as these, which will not be able to level up with the new set of standards laid down by regulators, will be forced to make substantial investment in research and development of their products, or they may get left out in this highly competitive market.
Many new trends related to China’s registration of veterinary drugs have the potential to impact markets for veterinary drugs throughout the world. As the Chinese market of veterinary drug grows, new investment opportunities come up for companies which have innovative products. The rampant use of such drugs as antibiotics and others in animal husbandry would also decrease in tandem with strict regulatory requirements. This would help the global issue of antibiotic resistance and can positively affect animal welfare. The consolidation within the industry could mean that those companies that will not meet the new regulatory standards will, as a matter of fact, leave the global market. On the whole, the new trends of the veterinary drug registration process in China may bring opportunities and challenges to the enterprises in the industry.
